Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy

Arms (1)

1. label

   Observational (medical record review)

   description

   Patients' medical records are reviewed retrospectively.

   interventionNames

   1. Other: Electronic Health Record Review

Primary outcomes (2)

1. measure

   To characterize cardiac events following standard of care (SOC)

   timeFrame

   through study completion, an average of 1 year

   description

   Summary statistics will be provided for patient demographic, and clinical and biological variables. Continuous variables will be presented as mean +/- standard deviation or median (interquartile range), as appropriate based on normality, and categorical variables will be presented as percentages. Continuous data will be compared with the use of unpaired Student's t-tests or Wilcoxon rank-sum tests, as appropriate. Categorical data will be compared using the chi-square or the Fisher exact test. Univariate analyses will be performed to determine the association between the time of cytokine release syndrome symptoms and tocilizumab administration with cardiovascular events. Statistical significance will be defined using a 2-tailed p value =\< 0.05.

2. measure